Dublin, Aug. 10, 2017 -- The "Pharma App Benchmarking 2017" report has been added to Research and Markets' offering.
Since the first report about the app publishing activities of leading Pharma companies was published in 2014, companies have intensified their activities in the digital health market. This report analyses the current status of the app publishing activities of the twelve leading Pharma companies globally. It also analyses newly established channels that Pharma use to partner with 3rd party companies, including accelerators/incubators, investment funds and direct partnerships.
The research provides a detailed perspective on the current status of digital health activities, on a market and company level. It compares the digital health activities that Pharma companies concentrate on, and how successful they are. The report also highlights how app publishing strategies have changed over the last three years.
Key Topics Covered:
1. Scope of the report
2. Management summary
3. The four channels used by Pharma to drive digital innovation with mHealth apps
4. The app publishing activities of top Pharma companies
5. Top 12 Pharma company app portfolio comparison
6. Top 12 Pharma company app profiles and digital health innovation activities
7. How can Pharma further evolve their digital health strategies?
8. Appendix
Companies Mentioned
- Abbott/Abbvie
- AstraZeneca
- Bayer Healthcare
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson&Johnson
- Merck
- Merck, Sharpe and Dohme (MSD)
- Novartis
- Pfizer
- Roche
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/c28hjv/pharma_app
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals


China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 



